Literature DB >> 22133324

Pharmacological management of acute and persistent aggression in forensic psychiatry settings.

Leslie Citrome1, Jan Volavka.   

Abstract

Aggressive behaviour is common in forensic psychiatric settings. The aetiology of aggressive behaviour is multifactorial and can be driven by psychosis, impulsivity, psychopathy, intoxication, cognitive impairment, or a combination of all of these. Recognition of the different factors behind the aggression can inform medication selection and the relative need for specific environmental and behavioural interventions in a forensic psychiatric setting. Acute agitation needs to be managed quickly and effectively before further escalation of the behavioural dyscontrol occurs. Benzodiazepines and/or antipsychotic medications are often used and can be given intramuscularly to achieve a rapid onset of action. Available are intramuscular preparations of second-generation antipsychotics that have similar efficacy to lorazepam and haloperidol in reducing agitation, but are well tolerated and not associated with the extrapyramidal adverse effects, including akathisia, that can plague the older first-generation antipsychotics. The longer-term management of persistent aggressive behaviour can be quite complex. A major obstacle is that the causality of aggressive events can differ from patient to patient, and also from event to event in the same patient. For patients with schizophrenia and persistent aggressive behaviour, clozapine is recommended both for its superior antipsychotic effect and its specific anti-hostility effect. Mood stabilizers such as valproate may be helpful in instances of poor impulsivity and personality disorders. Other agents that have been successfully used include β-adrenoceptor antagonists (β-blockers) and antidepressants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133324     DOI: 10.2165/11596930-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  77 in total

Review 1.  Bipolar disorder and aggression.

Authors:  K Látalová
Journal:  Int J Clin Pract       Date:  2009-06       Impact factor: 2.503

2.  Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.

Authors:  B J Kinon; S M Roychowdhury; D R Milton; A L Hill
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.

Authors:  J Battaglia; S Moss; J Rush; J Kang; R Mendoza; L Leedom; W Dubin; C McGlynn; L Goodman
Journal:  Am J Emerg Med       Date:  1997-07       Impact factor: 2.469

4.  Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.

Authors:  Horacio Preval; Steven G Klotz; Robert Southard; Andrew Francis
Journal:  Gen Hosp Psychiatry       Date:  2005 Mar-Apr       Impact factor: 3.238

5.  Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies.

Authors:  Jan Volavka; Pal Czobor; Leslie Citrome; Robert D McQuade; William H Carson; Dusan Kostic; Sterling Hardy; Ronald Marcus
Journal:  J Clin Psychiatry       Date:  2005-11       Impact factor: 4.384

6.  Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.

Authors:  Leslie Citrome; Jan Volavka; Pal Czobor; Shlomo Brook; Antony Loebel; Francine S Mandel
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

7.  Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.

Authors:  Michael H Allen; Martin Debanné; Coralie Lazignac; Eric Adam; L Miriam Dickinson; Cristian Damsa
Journal:  Am J Psychiatry       Date:  2011-01-18       Impact factor: 18.112

8.  Reducing inpatient aggression: does paying attention pay off?

Authors:  Karen A Nolan; Leslie Citrome
Journal:  Psychiatr Q       Date:  2008-06

9.  Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.

Authors:  Jan Volavka; Pal Czobor; Karen Nolan; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Thomas B Cooper; Jeffrey A Lieberman
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

10.  Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials.

Authors:  Stephen R Marder; Britt West; Gina S Lau; Joseph A Pultz; Andrei Pikalov; Ronald N Marcus; Rolando Gutierrez-Esteinou; David T Crandall
Journal:  J Clin Psychiatry       Date:  2007-05       Impact factor: 4.384

View more
  7 in total

Review 1.  Clozapine in Reducing Aggression and Violence in Forensic Populations.

Authors:  Kathleen Patchan; Gopal Vyas; Ann L Hackman; Marie Mackowick; Charles M Richardson; Raymond C Love; Ikwunga Wonodi; MacKenzie A Sayer; Matthew Glassman; Stephanie Feldman; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2018-03

2.  Modulation of aggressive behavior in mice by nicotinic receptor subtypes.

Authors:  Alan S Lewis; Yann S Mineur; Philip H Smith; Emma L M Cahuzac; Marina R Picciotto
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

3.  Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.

Authors:  G Fond; L Boyer; M Favez; L Brunel; B Aouizerate; F Berna; D Capdevielle; I Chereau; J M Dorey; C Dubertret; C Faget; F Gabayet; H Laouamri; C Lancon; Y Le Strat; D Misdrahi; R Rey; C Passerieux; A Schandrin; F Schurhoff; A M Tronche; M Urbach; P Vidalhet; P M Llorca; A Pelissolo
Journal:  Psychopharmacology (Berl)       Date:  2015-12-03       Impact factor: 4.530

Review 4.  Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.

Authors:  Mona M Boules; Paul Fredrickson; Amber M Muehlmann; Elliott Richelson
Journal:  Behav Sci (Basel)       Date:  2014-06-13

5.  Exploring substance use as rule-violating behaviour during inpatient treatment of offender patients with schizophrenia.

Authors:  Martina Sonnweber; Johannes Kirchebner; Moritz Philipp Günther; Johannes Rene Kappes; Steffen Lau
Journal:  Crim Behav Ment Health       Date:  2022-06-17

Review 6.  Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.

Authors:  Bernardo Dell'Osso; Umberto Albert; Anna Rita Atti; Claudia Carmassi; Giuseppe Carrà; Fiammetta Cosci; Valeria Del Vecchio; Marco Di Nicola; Silvia Ferrari; Arianna Goracci; Felice Iasevoli; Mario Luciano; Giovanni Martinotti; Maria Giulia Nanni; Alessandra Nivoli; Federica Pinna; Nicola Poloni; Maurizio Pompili; Gaia Sampogna; Ilaria Tarricone; Sarah Tosato; Umberto Volpe; Andrea Fiorillo
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-30       Impact factor: 2.570

Review 7.  Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues.

Authors:  Michael Weightman; Ranjit Kini; Robert Parker; Mrigendra Das
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.